These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 370089)

  • 1. Differential inhibition of bacterial growth and hemolysin production by lincosamide antibiotics.
    Shibl AM; Al-Sowaygh IA
    J Bacteriol; 1979 Feb; 137(2):1022-3. PubMed ID: 370089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduction of drug resistance to tetracycline, chloramphenicol, macrolides, lincomycin and clindamycin with phages induced from Streptococcus pyogenes.
    Ubukata K; Konno M; Fujii R
    J Antibiot (Tokyo); 1975 Sep; 28(9):681-8. PubMed ID: 1102514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes.
    Hyder SL; Streitfeld MM
    Antimicrob Agents Chemother; 1973 Sep; 4(3):327-31. PubMed ID: 4586147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of iron in the growth and hemolysin (Streptolysin S) production in Streptococcus pyogenes.
    Griffiths BB; McClain O
    J Basic Microbiol; 1988; 28(7):427-36. PubMed ID: 3065477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.
    Sawai J; Hasegawa T; Kamimura T; Okamoto A; Ohmori D; Nosaka N; Yamada K; Torii K; Ohta M
    Antimicrob Agents Chemother; 2007 Feb; 51(2):461-7. PubMed ID: 17101685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
    Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
    J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of date extract on growth and hemolytic activity of Streptococcus pyogenes.
    Hammad M; Sallal AK
    New Microbiol; 2002 Oct; 25(4):495-7. PubMed ID: 12437231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between erythromycin and lincomycin in Streptococcus pyogenes.
    Annear DI
    J Med Microbiol; 1978 May; 11(2):193-6. PubMed ID: 351184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subminimal inhibitory concentrations of chloramphenicol, erythromycin and penicillin on group A streptococci.
    Michel J; Ferne M; Borinski R; Kornberg Z; Bergner-Rabinowitz S; Ginsburg I
    Eur J Clin Microbiol; 1982 Dec; 1(6):375-80. PubMed ID: 6761113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and mechanisms of action of drugs on microorganisms. XVI. Effect of oleandomycin and its combinations with tetracycline, chloramphenicol, erythromycin, lincomycin, and 1'-demethyl-4'-depropyl-4'-(R and S)-n-pentylclindamycin on microbial generation of Escherichia coli.
    Won CM; Garrett ER
    J Pharm Sci; 1973 Jul; 62(7):1087-92. PubMed ID: 4576800
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro.
    Unkles SE; Gemmell CG
    Antimicrob Agents Chemother; 1982 Jan; 21(1):39-43. PubMed ID: 7081974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Streptococcus pyogenes group A--sensitivity to chemical preparations in vitro].
    Výmola F; Jedlicková Z
    Cas Lek Cesk; 1972 Mar; 111(13):292-4. PubMed ID: 4552005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
    Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M
    Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antibacterial activity of rifampicin and other antibiotics.
    McCabe WR; Lorian V
    Am J Med Sci; 1968 Oct; 256(4):255-65. PubMed ID: 4387027
    [No Abstract]   [Full Text] [Related]  

  • 15. Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes.
    Minami M; Kamimura T; Isaka M; Tatsuno I; Ohta M; Hasegawa T
    Antimicrob Agents Chemother; 2010 Jan; 54(1):98-102. PubMed ID: 19805566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus.
    Porter MC; Henderson BA; Healy PE; Coombs GW; Ingram PR; McLellan D; Clark B
    J Antimicrob Chemother; 2014 Mar; 69(3):856-7. PubMed ID: 24164721
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain Streptococcus pyogenes.
    Clewell DB; Franke AE
    Antimicrob Agents Chemother; 1974 May; 5(5):534-7. PubMed ID: 4618462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and characteristics of Streptococcus pyogenes resistant to lincomycin and erythromycin.
    Dixon JM; Lipinski AE
    J Med Microbiol; 1973 May; 6(2):Pxv. PubMed ID: 4575282
    [No Abstract]   [Full Text] [Related]  

  • 19. Multi drug resistance in group A hemolytic streptococci in Japan from 1972 to 1977.
    Yamada T; Kosakai N
    Jpn Circ J; 1980 Oct; 44(10):801-3. PubMed ID: 7001083
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of chromosomal mutations to erythromycin resistance with plasmid-mediated resistance to erythromycin and lincomycin in Streptococcus pyogenes.
    Malke H
    Z Allg Mikrobiol; 1977; 17(5):407-11. PubMed ID: 337688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.